ClinicalTrials.gg
CompletedNCT07794293Updated Oct 7, 2026

Comparison of Three Surgical Approaches for Lateral Sinus Floor Elevation

An interventional study of Conventional Rotary Lateral Sinus Floor Elevation and Epinephrine-Soaked Cotton Roll in Posterior Maxillary Atrophy and Maxillary Sinus Augmentation, sponsored by Istanbul Aydın University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Istanbul Aydın University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 years 3 months after the study started (first participant enrolled May 2021, registered Aug 2026).
Updated Oct 7, 2026Study documents postedEligibility revised+1 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
504
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study compares three surgical approaches used during lateral sinus floor elevation, a procedure performed to increase bone height in the back part of the upper jaw before or together with dental implant placement. Participants are randomly assigned to one of three groups: a standard surgical procedure, a technique using an epinephrine-soaked cotton roll to help control bleeding, or a piezoelectric surgical technique.

The study compares these approaches in terms of bleeding during surgery, visibility of the surgical field, ease of performing the procedure, operation time, and Schneiderian membrane perforation, an intraoperative complication that can occur during sinus lift surgery. Patient-related and anatomical factors, including age, sex, smoking status, residual bone height, sinus membrane thickness, lateral sinus wall thickness, and the presence of sinus septa, are also recorded.

The aim is to determine whether the surgical approach influences intraoperative conditions and membrane perforation and whether patient-related or anatomical factors are associated with these outcomes.

Read the detailed description

This single-center, prospective, randomized, three-arm clinical trial evaluated intraoperative conditions and Schneiderian membrane perforation during lateral sinus floor elevation (LSFE) performed using three surgical approaches. Eligible patients requiring LSFE for implant rehabilitation were randomized in a 1:1:1 ratio to the standard procedure (SP), epinephrine-soaked cotton roll technique (ESCR), or piezoelectric sinus lift (PESL) group. The randomization sequence was computer-generated by an independent statistician using variable permuted blocks of 6, 9, and 12 participants. Treatment allocation was concealed through a centralized electronic allocation system and was released only after eligibility had been confirmed and written informed consent had been obtained.

A standardized local anesthesia protocol was used in all three groups. Before incision, 3 mL of Ultracain D-S Forte, corresponding to 120 mg articaine hydrochloride and 0.036 mg epinephrine, was administered. In the SP group, the lateral window was prepared using conventional rotary instrumentation, and the Schneiderian membrane was elevated using conventional hand instruments. In the ESCR group, following completion of the lateral sinus wall osteotomy, a cottonoid saturated with an additional 1 mL of Ultracain D-S Forte, containing 40 mg articaine hydrochloride and 0.012 mg epinephrine, was applied to the surgical field for 5 minutes. After removal of the cottonoid, membrane elevation was continued using conventional hand instruments. In the PESL group, piezoelectric instruments were used for lateral-window preparation and membrane elevation, with conventional hand instruments used when required to complete membrane elevation. Subsequent grafting and implant-related procedures were performed according to standardized surgical protocols.

Patient-related and anatomical variables, including age, sex, smoking status, side of surgery, residual bone height (RBH), Schneiderian membrane thickness, lateral wall thickness (LWT), and the presence of maxillary sinus septa, were recorded preoperatively. Anatomical measurements were obtained from cone-beam computed tomography (CBCT) images. Schneiderian membrane perforation was assessed intraoperatively and recorded as a binary outcome (yes/no).

The four co-primary intraoperative outcomes were bleeding, surgical field visibility, procedural simplicity, and operation time. Bleeding, visibility, and procedural simplicity were assessed immediately after completion of surgery by the operating surgeon using 11-point numerical rating scales (NRSs; 0-10). For bleeding, 0 indicated no bleeding and 10 indicated excessive bleeding sufficient to compromise the surgical field. For visibility, 0 indicated the poorest possible surgical visibility and 10 indicated optimal visibility. For procedural simplicity, 0 indicated maximal procedural difficulty and 10 indicated the greatest ease of surgical handling. Operation time was measured using a stopwatch from initiation of the lateral-window osteotomy to completion of Schneiderian membrane elevation and was recorded in minutes, rounded to the nearest whole number; graft placement and implant placement were not included in the recorded operation time.

The primary objective was to compare the three surgical techniques with respect to the four co-primary intraoperative outcomes. Schneiderian membrane perforation constituted the principal secondary outcome. Additional secondary analyses evaluated whether the associations between intraoperative bleeding, visibility, and procedural simplicity and membrane perforation differed according to surgical technique. Associations of patient- and anatomy-related characteristics with intraoperative conditions and membrane perforation were also explored.

Statistical analyses included unadjusted between-group comparisons and multivariable analyses. The four co-primary outcomes were evaluated using separate multivariable linear regression models adjusted for age, RBH, sinus septa, smoking status, Schneiderian membrane thickness, and LWT, with heteroskedasticity-consistent HC3 standard errors. Membrane perforation was evaluated using multivariable binary logistic regression adjusted for the same patient- and anatomy-related covariates. Technique-dependent modification of the relationships between bleeding, visibility, procedural simplicity, and membrane perforation was assessed using separate multivariable logistic regression models containing surgical technique × intraoperative parameter interaction terms and adjusted for age, RBH, sinus septa, smoking status, Schneiderian membrane thickness, and LWT. Supportive exploratory analyses included correlation and non-parametric association analyses.

02

Conditions studied

  • Posterior Maxillary Atrophy
  • Maxillary Sinus Augmentation

Browse trials for

Keywords

  • Lateral Sinus Floor Elevation
  • Dental Implants
  • Schneiderian Membrane Perforation
  • Piezosurgery
  • Epinephrine-Soaked Cotton Roll
  • Surgical Simplicity
  • Surgical Visiblity
  • Operation Time
  • Residual Bone Height
03

In context

Atrophic Maxilla

30 studies on the registry are indexed under Atrophic Maxilla; 11 are open to participants now.

This study's enrollment of 504 is above the median of 16 across 27 interventional studies indexed under Atrophic Maxilla.

Browse Atrophic Maxilla studies →

Lead sponsor

Istanbul Aydın University is the lead sponsor of 70 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Sep 30, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Must be older than 18 years
  • Clinical diagnosis of absence of one or more maxillary posterior molars with a healing period of at least 6 months after extraction
  • Clinical indication for Lateral Sinus Floor Elevation with either simultaneous or delayed implant placement; residual bone height ≤5 mm at the planned implant site
  • Must be confirmed by cone-beam computed tomography (CBCT)
  • Must have an availability of complete medical, clinical, and radiographic records.

Exclusion criteria

Exclusion Criteria:

  • Uncontrolled systemic disease
  • Known bleeding or coagulation disorders, including thrombocytopenia or dysfunction
  • Current use of anticoagulant or antiplatelet medications
  • Pathological sinus mucosal thickening or other radiographic or clinical evidence of sinus disease
  • Untreated periapical or periodontal infection adjacent to the maxillary sinus
  • Antiresorptive therapy
  • History of head and neck radiotherapy
  • Requirement for additional vertical or horizontal bone augmentation procedures other than LSFE
  • Previous LSFE involving the same maxillary sinus
  • Schneiderian membrane thickness >4 mm on preoperative CBCT in otherwise clinically and radiographically healthy sinuses
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

Platelets

Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
504 participants (actual)

Study arms

  • Active comparator
    Conventional Rotary Lateral Sinus Floor Elevation (SP)

    The lateral sinus window was prepared using a rotary round diamond bur. After removal of the bony window, the Schneiderian membrane was elevated using conventional manual sinus instruments.

    Procedure: Conventional Rotary Lateral Sinus Floor Elevation

  • Experimental
    Epinephrine-Soaked Cotton Roll (ESCR)

    The lateral sinus window was prepared using a rotary round diamond bur. Following completion of the lateral sinus wall osteotomy, a cottonoid was saturated with an additional 1 mL of Ultracain D-S Forte, containing 40 mg articaine hydrochloride and 0.012 mg epinephrine, and applied to the surgical field for 5 minutes. After removal of the cottonoid, Schneiderian membrane elevation was continued using conventional manual sinus instruments.

    Procedure: Epinephrine-Soaked Cotton Roll

  • Experimental
    Piezoelectric Sinus Lift (PESL)

    The lateral sinus window was prepared using US2 and UL4 piezoelectric surgical tips. The Schneiderian membrane was elevated using UL2 and UL5 piezoelectric inserts, supplemented with conventional manual sinus instruments when necessary.

    Procedure: Piezoelectric Sinus Lift

Interventions

  • ProcedureConventional Rotary Lateral Sinus Floor Elevation

    A lateral sinus window is created using a rotary round diamond bur. After removal of the bony window, the Schneiderian membrane is elevated using conventional manual sinus instruments. Membrane integrity is evaluated by direct visualization and the Valsalva maneuver. Subsequent grafting and implant-related procedures are performed according to the standardized study protocol.

    Also known as: Standard Procedure, SP

  • ProcedureEpinephrine-Soaked Cotton Roll

    A lateral sinus window is created using a rotary round diamond bur. Following completion of the lateral sinus wall osteotomy, a cottonoid saturated with an additional 1 mL of Ultracain D-S Forte, containing 40 mg articaine hydrochloride and 0.012 mg epinephrine, is applied to the surgical field for 5 minutes to promote local hemostasis. After removal of the cottonoid, Schneiderian membrane elevation is continued using conventional manual sinus instruments. Subsequent procedures follow the standardized study protocol.

    Also known as: Epinephrine-Soaked Cottonoid-Assisted Lateral Sinus Floor Elevation, ESCR

  • ProcedurePiezoelectric Sinus Lift

    The lateral sinus window is created using US2 and UL4 piezoelectric surgical tips. The Schneiderian membrane is subsequently elevated using UL2 and UL5 piezoelectric inserts, supplemented with conventional manual sinus instruments when necessary. Membrane integrity is evaluated by direct visualization and the Valsalva maneuver. Subsequent grafting and implant-related procedures are performed according to the standardized study protocol.

    Also known as: Piezoelectric Lateral Sinus Floor Elevation, PESL

06

What researchers measure

Primary outcomes

  1. Intraoperative bleeding score

    Intraoperative bleeding was assessed immediately after surgery by the operating surgeon using an 11-point numerical rating scale (NRS; 0-10). A score of 0 indicated no bleeding, whereas a score of 10 indicated excessive bleeding sufficient to compromise the surgical field. Higher scores represented greater intraoperative bleeding.

    Time frame: Immediately after completion of surgery

  2. Surgical Field Visibility Score

    Surgical field visibility was assessed immediately after surgery by the operating surgeon using an 11-point numerical rating scale (NRS; 0-10). A score of 0 indicated the poorest possible surgical visibility, whereas a score of 10 indicated optimal visibility. Higher scores represented better surgical field visibility.

    Time frame: Immediately after completion of surgery

  3. Procedural Simplicity Score

    Procedural simplicity was assessed immediately after surgery by the operating surgeon using an 11-point numerical rating scale (NRS; 0-10). A score of 0 indicated maximal procedural difficulty, whereas a score of 10 indicated the greatest ease of surgical handling. Higher scores represented greater procedural simplicity.

    Time frame: Immediately after completion of surgery

  4. Operation time

    Operation time was measured using a stopwatch from initiation of the lateral-window osteotomy to completion of Schneiderian membrane elevation and was recorded in minutes, rounded to the nearest whole number. Graft placement and implant placement were not included in the recorded operation time. Higher values indicated a longer operative duration.

    Time frame: From the start to the completion of sinus membrane elevation

Secondary outcomes

  1. Intraoperative Schneiderian Membrane Perforation

    Schneiderian membrane perforation is assessed intraoperatively by direct visualization and the Valsalva maneuver and recorded as a binary outcome (yes/no). The outcome is reported as the number and percentage of participants experiencing membrane perforation in each intervention group.

    Time frame: During the surgical procedure, through completion of sinus membrane elevation

07

Study locations

1 site
  • Istanbul Aydin University
    Istanbul, 34295, Turkey (Türkiye)
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Individual participant-level data will not be made publicly available because of participant confidentiality and institutional data-protection requirements. Aggregated data may be available from the corresponding author upon reasonable request, subject to ethical and institutional approval.

09

Updates

2 registry updates since Sep 25, 2026
Eligibility
5 exclusion criteria added, 1 removed
What changed in the criteria
Exclusion criteria
  • AddedUncontrolled systemic disease
  • AddedKnown bleeding or coagulation disorders, including clinically relevant thrombocytopenia or platelet dysfunction
  • AddedCurrent use of anticoagulant or antiplatelet medications
  • RemovedCurrent or previous exposure to antiresorptive agents (e.g., bisphosphonates or denosumab) or antiangiogenic medication
  • AddedAntiresorptive therapy
  • AddedSchneiderian membrane thickness >4 mm on preoperative CBCT in otherwise clinically and radiographically healthy sinuses
Sep 30, 2026
Primary outcomes
4 description edited
What changed in the outcomes
  • DescriptionIntraoperative bleeding score: how it is measured was reworded
  • DescriptionOperation time: how it is measured was reworded
  • DescriptionProcedural Simplicity Score: how it is measured was reworded
  • DescriptionSurgical Field Visibility Score: how it is measured was reworded
Sep 30, 2026
Show all 2 updates
  1. Oct 7, 2026
    + 1 other change: verification date
  2. Sep 30, 2026
    Eligibility 5 exclusion criteria added, 1 removed
    What changed in the criteria
    Exclusion criteria
    • AddedUncontrolled systemic disease
    • AddedKnown bleeding or coagulation disorders, including clinically relevant thrombocytopenia or platelet dysfunction
    • AddedCurrent use of anticoagulant or antiplatelet medications
    • RemovedCurrent or previous exposure to antiresorptive agents (e.g., bisphosphonates or denosumab) or antiangiogenic medication
    • AddedAntiresorptive therapy
    • AddedSchneiderian membrane thickness >4 mm on preoperative CBCT in otherwise clinically and radiographically healthy sinuses
    Primary outcomes 4 description edited
    What changed in the outcomes
    • DescriptionIntraoperative bleeding score: how it is measured was reworded
    • DescriptionOperation time: how it is measured was reworded
    • DescriptionProcedural Simplicity Score: how it is measured was reworded
    • DescriptionSurgical Field Visibility Score: how it is measured was reworded
    + 3 other changes: description, design details and arm descriptions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07794293
Lead sponsor
Istanbul Aydın University
Responsible party
Mehmet Kagan Degerliyurt (Professor of Oral and Maxillofacial Surgery, Istanbul Aydın University) — Principal investigator
First posted
Aug 31, 2026
Start date
May 1, 2021
Primary completion
Jul 24, 2026
Completion
Jul 24, 2026
Last update
Oct 7, 2026

Study contacts

Mehmet Kagan Degerliyurt, DDS, PhD
principal investigator · Istanbul Aydın University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion